IN2014CN04945A - - Google Patents

Info

Publication number
IN2014CN04945A
IN2014CN04945A IN4945CHN2014A IN2014CN04945A IN 2014CN04945 A IN2014CN04945 A IN 2014CN04945A IN 4945CHN2014 A IN4945CHN2014 A IN 4945CHN2014A IN 2014CN04945 A IN2014CN04945 A IN 2014CN04945A
Authority
IN
India
Prior art keywords
formula
sitaxsentan
retains
formulas
represented
Prior art date
Application number
Other languages
English (en)
Inventor
Keigo Tanaka
Tomoki Nishioka
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of IN2014CN04945A publication Critical patent/IN2014CN04945A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
IN4945CHN2014 2012-01-31 2013-01-29 IN2014CN04945A (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261592923P 2012-01-31 2012-01-31
PCT/JP2013/051857 WO2013115162A1 (ja) 2012-01-31 2013-01-29 シタキセンタン誘導体

Publications (1)

Publication Number Publication Date
IN2014CN04945A true IN2014CN04945A (enrdf_load_html_response) 2015-09-18

Family

ID=48870751

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4945CHN2014 IN2014CN04945A (enrdf_load_html_response) 2012-01-31 2013-01-29

Country Status (16)

Country Link
US (1) US8592470B2 (enrdf_load_html_response)
EP (1) EP2810943B1 (enrdf_load_html_response)
JP (1) JP6144631B2 (enrdf_load_html_response)
KR (1) KR101933251B1 (enrdf_load_html_response)
CN (1) CN104039781B (enrdf_load_html_response)
AR (1) AR089838A1 (enrdf_load_html_response)
AU (1) AU2013216122B9 (enrdf_load_html_response)
BR (1) BR112014016204B1 (enrdf_load_html_response)
CA (1) CA2861477C (enrdf_load_html_response)
ES (1) ES2651293T3 (enrdf_load_html_response)
IL (1) IL233171A (enrdf_load_html_response)
IN (1) IN2014CN04945A (enrdf_load_html_response)
MX (1) MX358151B (enrdf_load_html_response)
RU (1) RU2622386C2 (enrdf_load_html_response)
TW (1) TW201336496A (enrdf_load_html_response)
WO (1) WO2013115162A1 (enrdf_load_html_response)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022270487A1 (ja) 2021-06-22 2022-12-29 株式会社アークメディスン 化合物、エンドセリンa受容体拮抗剤及び医薬組成物
AR131023A1 (es) * 2022-11-11 2025-02-12 Alchemedicine Inc Compuesto, antagonista del receptor de endotelina a, antagonista del receptor de angiotensina ii de tipo 1 y composición farmacéutica
WO2024242594A1 (ru) * 2023-05-23 2024-11-28 Общество С Ограниченной Ответственностью "Ифар" Средство для лечения легочных гипертензий

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861366A (en) 1984-08-27 1989-08-29 E. I. Du Pont De Nemours And Company Herbicidal acetals and ketals
US4659369A (en) 1984-08-27 1987-04-21 E. I. Du Pont De Nemours And Company Herbicidal acetals and ketals
US4753672A (en) 1985-07-16 1988-06-28 E. I. Du Pont De Nemours And Company Herbicidal acetals and ketals
TW224462B (enrdf_load_html_response) * 1992-02-24 1994-06-01 Squibb & Sons Inc
KR100359396B1 (ko) 1995-04-04 2003-03-15 텍사스 바이오테크놀로지 코포레이션 엔도텔린의활성을조절하는티에닐-,푸릴-및피롤릴설폰아미드및이의유도체
ATE286051T1 (de) * 1999-12-31 2005-01-15 Encysive Pharmaceuticals Inc Sulfonamide und ihre derivate, die die aktivität des endothelins modulieren
US20060205733A1 (en) * 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
JP2010523694A (ja) * 2007-04-10 2010-07-15 オースペックス・ファーマシューティカルズ・インコーポレイテッド 高血圧治療のための置換重水素濃縮チオフェン

Also Published As

Publication number Publication date
MX2014007619A (es) 2014-09-15
KR101933251B1 (ko) 2018-12-27
EP2810943A4 (en) 2015-09-02
JP6144631B2 (ja) 2017-06-07
JPWO2013115162A1 (ja) 2015-05-11
MX358151B (es) 2018-08-07
BR112014016204A2 (pt) 2017-06-13
ES2651293T3 (es) 2018-01-25
EP2810943A1 (en) 2014-12-10
RU2014126427A (ru) 2016-03-20
US8592470B2 (en) 2013-11-26
AR089838A1 (es) 2014-09-17
AU2013216122B9 (en) 2017-02-02
CN104039781A (zh) 2014-09-10
CN104039781B (zh) 2016-08-17
US20130197045A1 (en) 2013-08-01
KR20140117455A (ko) 2014-10-07
WO2013115162A1 (ja) 2013-08-08
AU2013216122A1 (en) 2014-07-24
BR112014016204B1 (pt) 2020-09-24
TW201336496A (zh) 2013-09-16
IL233171A0 (en) 2014-07-31
BR112014016204A8 (pt) 2017-07-04
AU2013216122B2 (en) 2016-12-08
EP2810943B1 (en) 2017-09-27
CA2861477A1 (en) 2013-08-08
CA2861477C (en) 2018-01-02
RU2622386C2 (ru) 2017-06-15
IL233171A (en) 2017-07-31

Similar Documents

Publication Publication Date Title
CA2875877C (en) Syk inhibitors
PH12014501719A1 (en) Pyridone derivatives
MY180083A (en) Tetrahydropyrrolothiazine compounds
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
RS53301B (en) TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES
PH12016500169A1 (en) Polymorph of syk inhibitors
MX2017010735A (es) Inhibidores de inhibidores del factor beta de crecimiento de transformacion (tgf-beta).
AU2012214029A8 (en) Rorgammat inhibitors
IN2014MN01897A (enrdf_load_html_response)
AU2012313888A8 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
UA116923C2 (uk) (6S,9aS)-N-БЕНЗИЛ-6-[(4-ГІДРОКСИФЕНІЛ)МЕТИЛ]-4,7-ДІОКСО-8-({6-[3-(ПІПЕРАЗИН-1-ІЛ)АЗЕТИДИН-1-ІЛ]ПІРИДИН-2-ІЛ}МЕТИЛ)-2-(ПРОП-2-ЕН-1-ІЛ)-ОКТАГІДРО-1H-ПІРАЗИНО[2,1-c][1,2,4]ТРИАЗИН-1-КАРБОКСАМІДНА СПОЛУКА
RS54730B1 (sr) Inhibitori beta sekretaze
PH12016500148A1 (en) Plant disease control composition and its use
IN2014DN07509A (enrdf_load_html_response)
MX2014002833A (es) Derivados fungicidas de 3-fenil[(heterociclilmetoxi)imino]metil}-1 ,2,4-oxadiazol-5(4h)-ona sustituidos en 4.
MA40171A (fr) Dérivés d'azamophinan et leur utilisation
MA40170A (fr) Dérivés hétérocycliques de morphinan et leur utilisation
MA39866A (fr) Amides 2-amino-6-méthyl-4,4a,5,6-tétrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yle
IN2014CN04204A (enrdf_load_html_response)
PH12015502429A1 (en) Dicarboxylic acid compound
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
IN2013CN01335A (enrdf_load_html_response)
MY185971A (en) Pyranodipyridine compound
MX359399B (es) Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
NZ605804A (en) New aminopyrazoloquinazolines